Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 145
11
Diseases
5
Unique genes
0.412
Avg. similarity score
Colon inflammatory polyp
Most-connected disease (9 links)
Disease
Searched: Thymoma type b1
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Thymoma type b1
Colon inflammatory polyp
Gastrointestinal polyp
Gastrointestinal stromal tumor/gist-plus syndrome, somatic or familial
Hyper eosinophilic advanced snydrome
Nasal cavity and paranasal sinus neoplasm
Congenital respiratory system anomaly
Eosinophilic leukemia
Gist-plus syndrome
Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal
Rienhoff syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Colon inflammatory polyp | 9 | 9 | 1 |
| Gastrointestinal polyp | 9 | 9 | 1 |
| Gastrointestinal stromal tumor/gist-plus syndrome, somatic or familial | 9 | 9 | 1 |
| Hyper eosinophilic advanced snydrome | 9 | 9 | 1 |
| Nasal cavity and paranasal sinus neoplasm | 9 | 9 | 1 |
| Congenital respiratory system anomaly | 6 | 6 | 3 |
| Eosinophilic leukemia | 5 | 5 | 2 |
| Gist-plus syndrome | 5 | 5 | 1 |
| Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal | 5 | 5 | 1 |
| Thymoma type b1 | 5 | 5 | 2 |
| Rienhoff syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PDGFRA | 10 / 11 | Colon inflammatory polyp, Congenital respiratory system anomaly, Eosinophilic leukemia, Gastrointestinal polyp and 6 more |
| TGFB3 | 2 / 11 | Congenital respiratory system anomaly, Rienhoff syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Molecules associated with elastic fibres | Reactome | 2 / 38 | 126× | 9.69e-5 | 1.85e-3 ✓ sig. |
| MAPK signaling pathway | KEGG | 3 / 299 | 24.1× | 1.47e-4 | 2.58e-3 ✓ sig. |
| Malaria | KEGG | 2 / 50 | 96.1× | 1.69e-4 | 2.87e-3 ✓ sig. |
| Inflammatory bowel disease | KEGG | 2 / 66 | 72.8× | 2.94e-4 | 4.44e-3 ✓ sig. |
| Renal cell carcinoma | KEGG | 2 / 70 | 68.6× | 3.31e-4 | 4.86e-3 ✓ sig. |
| Pancreatic cancer | KEGG | 2 / 77 | 62.4× | 4.01e-4 | 5.63e-3 ✓ sig. |
| Chronic myeloid leukemia | KEGG | 2 / 77 | 62.4× | 4.01e-4 | 5.63e-3 ✓ sig. |
| Leishmaniasis | KEGG | 2 / 78 | 61.6× | 4.11e-4 | 5.74e-3 ✓ sig. |
| Imatinib-resistant PDGFR mutants | Reactome | 1 / 1 | 2,402× | 4.16e-4 | 5.79e-3 ✓ sig. |
| Sunitinib-resistant PDGFR mutants | Reactome | 1 / 1 | 2,402× | 4.16e-4 | 5.79e-3 ✓ sig. |
| Regorafenib-resistant PDGFR mutants | Reactome | 1 / 1 | 2,402× | 4.16e-4 | 5.79e-3 ✓ sig. |
| Sorafenib-resistant PDGFR mutants | Reactome | 1 / 1 | 2,402× | 4.16e-4 | 5.79e-3 ✓ sig. |
| PDGFR mutants bind TKIs | Reactome | 1 / 1 | 2,402× | 4.16e-4 | 5.79e-3 ✓ sig. |
| Colorectal cancer | KEGG | 2 / 87 | 55.2× | 5.11e-4 | 6.78e-3 ✓ sig. |
| Rheumatoid arthritis | KEGG | 2 / 95 | 50.6× | 6.10e-4 | 7.79e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| face morphogenesis | GO:0060325 | 3 / 33 | 340× | 5.01e-8 | 7.08e-6 ✓ sig. |
| uterine wall breakdown | GO:0042704 | 2 / 2 | 3,737× | 5.73e-8 | 7.95e-6 ✓ sig. |
| salivary gland morphogenesis | GO:0007435 | 2 / 10 | 747× | 2.58e-6 | 1.86e-4 ✓ sig. |
| transforming growth factor beta receptor superfamily signaling pathway | GO:0141091 | 2 / 11 | 680× | 3.15e-6 | 2.18e-4 ✓ sig. |
| negative regulation of macrophage cytokine production | GO:0010936 | 2 / 12 | 623× | 3.78e-6 | 2.53e-4 ✓ sig. |
| secondary palate development | GO:0062009 | 2 / 14 | 534× | 5.21e-6 | 3.27e-4 ✓ sig. |
| positive regulation of cellular component organization | GO:0051130 | 2 / 16 | 467× | 6.86e-6 | 4.06e-4 ✓ sig. |
| cell-cell junction organization | GO:0045216 | 2 / 29 | 258× | 2.32e-5 | 1.03e-3 ✓ sig. |
| response to progesterone | GO:0032570 | 2 / 31 | 241× | 2.66e-5 | 1.14e-3 ✓ sig. |
| positive regulation of multicellular organismal process | GO:0051240 | 2 / 35 | 214× | 3.40e-5 | 1.38e-3 ✓ sig. |
| odontogenesis | GO:0042476 | 2 / 36 | 208× | 3.60e-5 | 1.44e-3 ✓ sig. |
| positive regulation of SMAD protein signal transduction | GO:0060391 | 2 / 42 | 178× | 4.91e-5 | 1.82e-3 ✓ sig. |
| positive regulation of cell division | GO:0051781 | 2 / 48 | 156× | 6.43e-5 | 2.23e-3 ✓ sig. |
| positive regulation of protein secretion | GO:0050714 | 2 / 49 | 153× | 6.70e-5 | 2.29e-3 ✓ sig. |
| positive regulation of epithelial to mesenchymal transition | GO:0010718 | 2 / 59 | 127× | 9.74e-5 | 3.03e-3 ✓ sig. |